Featured content

Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergence™ AI Platform

Read more

Fauna Bio Announces Strategic Collaboration with Lilly to Discover Novel Obesity Targets Using Convergence™ AI Platform

Read more

Fauna Bio Featured in WSJ: Studies Animal Genomes for Clues to Human Diseases

Read more

Fauna Bio Featured in WSJ: Studies Animal Genomes for Clues to Human Diseases

Read more

Fauna Bio CEO interviewed by Drug Discovery and Development on the advantages of tapping extreme mammals for human disease breakthroughs

Read more

Fauna Bio CEO interviewed by Drug Discovery and Development on the advantages of tapping extreme mammals for human disease breakthroughs

Read more

Latest from Fauna Bio

Jun 7, 2018

Science of rhythm nightlife at the California Academy of Sciences

2018

Read more

Science of rhythm nightlife at the California Academy of Sciences

2018

Read more

May 18, 2018

Fauna bio receives investment from the longevity fund and is accepted into the age1 accelerator program

2018

Read more

Fauna bio receives investment from the longevity fund and is accepted into the age1 accelerator program

2018

Read more

Company

About Us Our Approach Resources

Contact

hello@faunabio.com

6460 Hollis St., Suite A Emeryville, CA 94608

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

© 2024 Fauna Bio